Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer

被引：0
|
作者：
E Mochiki
K Ogata
T Ohno
Y Toyomasu
N Haga
Y Fukai
R Aihara
H Ando
N Uchida
T Asao
H Kuwano
机构：
[1] Graduate School of Medicine,Department of General Surgical Science
[2] Gunma University,Department of Surgery
[3] Gunma Prefecture Saiseikai-Maebashi Hospital,Department of Surgery
[4] Saitama Medical Center,Department of Surgery
[5] Gunma Cancer Center Hospital,Department of Surgery
[6] Fujioka General Hospital,Department of Surgery
[7] Haramachi Red Cross Hospital,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
gastric cancer; chemotherapy; S-1; paclitaxel; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：31 / 36
页数：5
相关论文
共 50 条
  • [21] Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer
    Narahara, Hiroyuki
    Fujitani, Kazumasa
    Takiuchi, Hiroya
    Sugimoto, Naotoshi
    Inoue, Kentaro
    Uedo, Noriya
    Tsukuma, Hideaki
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    ONCOLOGY, 2008, 74 (1-2) : 37 - 41
  • [22] Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
    Kawabata, Ryohei
    Fujiwara, Yoshiyuki
    Doki, Yuichiro
    Fujita, Junya
    Tsukahara, Yasuo
    Yamasaki, Makoto
    Miyata, Hiroshi
    Takiguchi, Shuji
    Monden, Morito
    ONCOLOGY, 2007, 72 (3-4) : 219 - 225
  • [23] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2013, 109 : 2079 - 2086
  • [24] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    Koizumi, W.
    Yamaguchi, K.
    Hosaka, H.
    Takinishi, Y.
    Nakayama, N.
    Hara, T.
    Muro, K.
    Baba, H.
    Sasaki, Y.
    Nishina, T.
    Fuse, N.
    Esaki, T.
    Takagi, M.
    Gotoh, M.
    Sasaki, T.
    BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2079 - 2086
  • [25] Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer
    Inoue, K.
    Nakane, Y.
    Kogire, M.
    Fujitani, K.
    Kimura, Y.
    Imamura, H.
    Tamura, S.
    Okano, S.
    Kwon, A. H.
    Kurokawa, Y.
    Shimokawa, T.
    Takiuchii, H.
    Tsujinaka, T.
    Furukawa, H.
    EJSO, 2012, 38 (02): : 143 - 149
  • [26] A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
    Kaufman, DS
    Carducci, MA
    Kuzel, TM
    Todd, MB
    Oh, WK
    Smith, MR
    Ye, ZS
    Nicol, SJ
    Stadle, WM
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 393 - 397
  • [27] A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
    Akihiro Nakajo
    Shuichi Hokita
    Sumiya Ishigami
    Futoshi Miyazono
    Tadaaki Etoh
    Masahiro Hamanoue
    Shigeho Maenohara
    Toshimitsu Iwashita
    Hideaki Komatsu
    Kiyoharu Satoh
    Kuniaki Aridome
    Satoshi Morita
    Shoji Natsugoe
    Hiroya Takiuchi
    Shyuji Nakano
    Yoshihiko Maehara
    Junichi Sakamoto
    Takashi Aikou
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1103 - 1109
  • [28] A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
    Nakajo, Akihiro
    Hokita, Shuichi
    Ishigami, Sumiya
    Miyazono, Futoshi
    Etoh, Tadaaki
    Hamanoue, Masahiro
    Maenohara, Shigeho
    Iwashita, Toshimitsu
    Komatsu, Hideaki
    Satoh, Kiyoharu
    Aridome, Kuniaki
    Morita, Satoshi
    Natsugoe, Shoji
    Takiuchi, Hiroya
    Nakano, Shyuji
    Maehara, Yoshihiko
    Sakamoto, Junichi
    Aikou, Takashi
    Taxol, Kyushu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 1103 - 1109
  • [29] Erratum: Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2014, 111 : 2382 - 2382
  • [30] A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
    Uemura, Naoki
    Kikuchi, Shohei
    Sato, Yasushi
    Ohnuma, Hiroyuki
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Hirakawa, Masahiro
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Takahashi, Yasuo
    Okuda, Toshinori
    Minami, Shinya
    Takahashi, Minoru
    Okamoto, Tetsuro
    Takada, Kohichi
    Miyanisi, Koji
    Takayama, Tetsuji
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 707 - 713
12345